We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Ranbaxy, Glaxo Bury Hatchet Over Valtrex

Law360 (July 26, 2007, 12:00 AM EDT) -- In a boost to Ranbaxy Laboratories Ltd., the Indian drug giant has won 180 days of exclusive rights to sell a generic version of GlaxoSmithKline's Valtrex in the United States after...
To view the full article, register now.